Using a blood test to detect kidney injury from contrast dye
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease (CKD).
- You are scheduled for a CT scan or heart angiography using Omnipaque contrast dye.
- You are not on dialysis.
- You are not pregnant and are not in prison or jail.
- You have not had any other contrast dye within 2 days before or after your procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a blood test called cystatin C can help detect acute kidney injury early in people who are having a heart attack and need a procedure to open blocked arteries (angioplasty). It may help doctors identify kidney problems sooner so they can protect your kidneys.
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This trial uses contrast-enhanced ultrasound to look for early signs of acute kidney injury in intensive care patients. The goal is to see if this imaging test can help diagnose kidney problems sooner, which could lead to faster treatment.
This study uses a simple ultrasound test (kidney artery scan) to see if it can predict kidney problems early in people who are very ill. It may help doctors protect your kidneys during your hospital stay.
This trial studies whether a blood test called delta C-cistatin can help doctors predict when patients can safely stop continuous kidney dialysis after acute kidney injury.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.